Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Repligen Corp shares valued at $3,271,688 were sold by Hunt Anthony on May 15 ’25. At $123.71 per share, Hunt Anthony sold 26,447 shares. The insider’s holdings dropped to 109,854 shares worth approximately $13.23 million following the completion of this transaction.
Also, Hunt Anthony purchased 26,447 shares, netting a total of over 3,394,208 in proceeds.
Before that, Hunt Anthony had sold 26,756 shares from its account. In a trade valued at $4,080,663, the Director traded Repligen Corp shares for $152.51 each. Upon closing the transaction, the insider’s holdings decreased to 26,756 shares, worth approximately $16.42 million.
As published in a research note from Wolfe Research on April 29, 2025, Repligen Corp [RGEN] has been rated up from a Peer perform to an Outperform and the price target has been revised to $160. Analysts at Evercore ISI started covering the stock with ‘”an In-line”‘ outlook in a report released in mid March. As of February 10, 2025, TD Cowen has initiated its “Buy” rating for RGEN. Earlier on December 17, 2024, Canaccord Genuity initiated its rating. Their recommendation was “a Hold” for RGEN stock.
Analyzing RGEN Stock Performance
During the last five days, there has been a drop of approximately -2.28%. Over the course of the year, Repligen Corp shares have dropped approximately -16.32%. Shares of the company reached a 52-week high of $182.52 on 01/28/25 and a 52-week low of $102.96 on 04/07/25.
Support And Resistance Levels for Repligen Corp (RGEN)
According to the 24-hour chart, there is a support level at 118.78, which, if violated, would cause prices to drop to 117.10. In the upper region, resistance lies at 121.86. The next price resistance is at 123.26. RSI (Relative Strength Index) is 40.03 on the 14-day chart, showing neutral technical sentiment.
